Souhaitez-vous accéder aux communiqués récents ?

– No changes in protocol recommended for LUGANO and LUCIA clinical trials – – Masked safety data continues to show no safety signals, consistent with previous clinical trials for DURAVYU – – On...

NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...

California, US,, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Nov. 19, 2025 - BitStarz has built a strong reputation in the trending real money no deposit bonus casinos sector since its 2014 launch, emerging...

Company Announcement EPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is the first and only bispecific-based therapy approved by the FDA for follicular lymphoma in the second-line settingIn the...

LOUISVILLE, Ky. , Nov. 17, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Kura Oncology for Komzifti™...

BRIDGEWATER, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced the U.S. Food and Drug Administration (FDA) has approved...

The Purple Play Packs from Ageless Innovation will feature a selection of Ageless Innovation games, with proceeds supporting the Alzheimer’s Association

Applied StemCell uses TARGATT™ tech to insert a 50 kb multifunctional DNA construct into hiPSCs, enabling development of allogeneic iPSC-based therapies.

LOS ANGELES, Nov. 06, 2025 (GLOBE NEWSWIRE) -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology...

Azalea Therapeutics launches with $82M to advance precision in vivo genome engineering, creating therapeutic cells directly inside patients.